Parkinson's patients get Comtan (entacapone)

December 1999

You'll see more Parkinson's patients get Comtan (entacapone)...to enhance the effectiveness of levodopa/carbidopa (Sinemet, etc).

Comtan is a COMT inhibitor...in the same class as Tasmar (tolcapone). But Comtan isn't expected to have the same problems with hepatotoxicity as Tasmar.

COMT inhibitors slow the breakdown of levodopa...resulting in more stable and prolonged serum concentrations. This helps smooth out the response to levodopa.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote